abstract |
The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of a PCSK9-mediated disorder. The present invention further relates to methods of producing these agents, immunogenic compositions and pharmaceutical compositions thereof, and uses thereof in medicine. |